Clinical Study

The Effect of Omega-3 Docosahexaenoic Acid Supplementation on Gestational Length: Randomized Trial of Supplementation Compared to Nutrition Education for Increasing n-3 Intake from Foods

Table 1

Subject characteristics by group and comparison of those who completed study and those who withdrew from study.

Completed study 
Withdrew from study 

(, %)

CON ()12192 (43.2)
300 ()10793 (44.9)
600 ()117104 (47.0)
NEd ()19118 (8.6)
RBC DHA at entry − % Total FA (mean ± sem)
 CON3.43 ± 0.103.54 ± 0.12
 3003.67 ± 0.123.54 ± 0.12
 6003.47 ± 0.103.66 ± 0.11
Maternal BMI Kg/M2 (mean ± sem)
 CON25.09 ± 0.5025.69 ± 0.67
 30026.61 ± 0.5525.06 ± 0.65
 60025.29 ± 0.5425.31 ± 0.58
 NEd26.79 ± 0.4626.24 ± 1.30
Maternal age years (mean ± sem)
 CON25.1 ± 0.6124.2 ± 0.48
 30024.5 ± 0.6224.1 ± 0.45
 60024.3 ± 0.6223.5 ± 0.48
 NEd27.0 ± 0.5026.3 ± 1.32

CON: control; 300: 300 mg DHA/day; 600: 600 mg DHA/day; NEd: nutrition education.